Study of infections in cirrhosis from hepatitis B or C
Part of Digestive system, Infections clinical trials.
This study looks at infections in people with cirrhosis caused by hepatitis B or C. It aims to find which germs cause these infections, so doctors can choose better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are hospitalized for cirrhosis caused by hepatitis B or C.
- You are between 18 and 70 years old.
- You have had a positive hepatitis B surface antigen (HBsAg) test for at least 6 months.
- You have symptoms of liver failure or high blood pressure in the liver, and tests confirm cirrhosis.
- You agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the bacteria naturally living in your gut (the microbiome) to better understand liver cirrhosis. It does not test a new drug or treatment, only collects information and samples.
This study looks at the nutrition and dietary needs of people with cirrhosis (a type of long-term liver damage). It aims to understand how nutrition affects their health, so doctors can give better advice.
This study looks at what types of infections happen in people with severe hepatitis (liver failure). It aims to help doctors better understand and treat these infections. You may qualify if you have a long-term hepatitis B or recent hepatitis E infection and your liver function has gotten much worse quickly.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
This study looks at bacterial infections in people with cirrhosis to understand which antibiotics still work. The goal is to improve treatment for future patients with liver disease.
This study looks at women with chronic hepatitis B or C to understand their current health status. It may help researchers find better ways to support patients like you.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.